Trial · NCT03895099
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
NCT03895099, Phase 3, Completed, Centre Hospitalier Intercommunal Creteil
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors. Trials, record NCT03895099. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03895099
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
- NCT number
- NCT03895099
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 110 participants, actual
- Lead sponsor
- Centre Hospitalier Intercommunal Creteil
- Conditions
- Infertility
- Interventions
- Desogestrel early follicular phase, Desogestrel medium follicular phase, Desogestrel ovulatory phase, Desogestrel late follicular phase, Desogestrel luteal phase
- First posted
- 2019-03-29
- Last updated
- 2023-11-07
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of oocytes punctured | 45 days | Number of oocytes punctured after ovarian stimulation as described above, regardless of the phase of the menstrual cycle at the time of injection of corifollitropin alpha. |
| Secondary | Premature peak of LH | 45 days | Frequency of occurrence of a premature peak of LH |
| Secondary | Hyperstimulation syndrome | 45 days | Occurrence of moderate to severe ovarian hyperstimulation syndrome |
| Secondary | Number of injection | 45 days | Number of injection is needed to evaluate the stimulation parameters |
| Secondary | Number of Recombinant follicle stimulating hormone (r-FSH) units required for ovarian stimulation | 45 days | the number of r-FSH units required for ovarian stimulation is needed to evaluate the stimulation parameters |
| Secondary | Number of days of stimulation | 45 days | The number of day of stimulation is needed to evaluate the stimulation parameters |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 41373024 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03895099
GET https://conductscience.org/api/trials/v1/NCT03895099/registered